Insider · CIK 0001200503
Lisa M Harper
Files at CURV (Torrid Holdings Inc.). First filing Jun 30, 2025, latest Jun 30, 2025.
In brief
Lisa M Harper files SEC Form 4 as CEO and director at CURV (Torrid Holdings Inc.). Since Jun 30, 2025, Lisa M Harper has reported 0 open-market buys worth $0 and 1 open-market sell worth $1.2M, the latest filed on Jun 30, 2025.
A track record needs three past buys with six months of prices behind them; Lisa M Harper has 0, so none is measured yet.
The newest scored trade: sold $1.2M of CURV on Jun 26, 2025, filed Jun 30, 2025, scored 65 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CURV: Torrid Holdings Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 65Notable | Torrid Holdings Inc. | $1.2M 350,000 shares | -6% | +4% from low-54% from high |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 6, 2026 | CURV Torrid Holdings Inc. | FTax withholding Common Stock | -7,052 | $1.53 | $11k | 5,421,549 | May 7, 2026 |
| Mar 27, 2026 | CURV Torrid Holdings Inc. | FTax withholding Common Stock | -3,770 | $1.79 | $6,748 | 5,428,601 | Mar 31, 2026 |
| Mar 25, 2026 | CURV Torrid Holdings Inc. | FTax withholding Common Stock | -6,523 | $1.71 | $11k | 5,432,371 | Mar 27, 2026 |
| Mar 16, 2026 | CURV Torrid Holdings Inc. | AGrant or award Common Stock | +472,441 | $0.00 | $0 | 5,738,894 | Mar 18, 2026 |
| May 3, 2025 | CURV Torrid Holdings Inc. | DDisposition to issuer Common Stock | -300,000 | $0.00 | $0 | 5,438,894 | Mar 18, 2026 |
| Mar 16, 2026 | CURV Torrid Holdings Inc. | AGrant or award Option to purchase sharesderivative | +1,267,606 | $0.00 | $0 | 1,267,606 | Mar 18, 2026 |
| Jun 26, 2025 | CURV Torrid Holdings Inc. | SOpen-market sale Common Stock | -350,000 | $3.32 | $1.2M | 5,266,453 | Jun 30, 2025 |
| May 6, 2025 | CURV Torrid Holdings Inc. | FTax withholding Common Stock | -11,395 | $5.40 | $62k | 5,616,453 | May 7, 2025 |
| Mar 27, 2025 | CURV Torrid Holdings Inc. | FTax withholding Common Stock | -6,092 | $5.74 | $35k | 5,627,848 | Mar 31, 2025 |
| Mar 25, 2025 | CURV Torrid Holdings Inc. | AGrant or award Common Stock | +107,143 | $0.00 | $0 | 5,633,940 | Mar 27, 2025 |
| Mar 25, 2025 | CURV Torrid Holdings Inc. | AGrant or award Option to purchase sharesderivative | +292,208 | $0.00 | $0 | 292,208 | Mar 27, 2025 |
| Dec 5, 2024 | CURV Torrid Holdings Inc. | AGrant or award Common Stock | +6,869 | $3.64 | $25k | 5,528,470 | Dec 9, 2024 |
| Dec 5, 2024 | CURV Torrid Holdings Inc. | FTax withholding Common Stock | -1,673 | $3.64 | $6,090 | 5,526,797 | Dec 9, 2024 |
| Mar 27, 2024 | CURV Torrid Holdings Inc. | FTax withholding Common Stock | -3,770 | $4.59 | $17k | 5,978,570 | Mar 28, 2024 |
Questions about Lisa M Harper
Answered from the filings on this page, as of the latest one.
Is Lisa M Harper buying or selling?
Not in the last 12 months. Lisa M Harper's latest open-market trade on SEC Form 4 was sold $1.2M of CURV on Jun 26, 2025.
How did Lisa M Harper's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lisa M Harper has 0.
Where does Lisa M Harper file Form 4?
Lisa M Harper has filed Form 4 at CURV (Torrid Holdings Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.